Live from the NIH registry
Studies recruiting near Madison right now
Top 25 of 528 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
UW Health Comprehensive Program for Bleeding Disorders — Madison, Wisconsin (0.8 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
RESISTance Exercise for Depression Trial
Major Depressive Disorder
N/A
Interventional 200 participants sought
University of Wisconsin - Madison — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
University of Wisconsin Carbone Cancer Center - University Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Painful Post-Operative Hip Study
Unilateral Hip Arthroscopy
Phase 2
Interventional 15 participants sought
University of Wisconsin - Madison — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Anagram Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: SWOG Cancer Research Network
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
ERα+ Breast Cancer, ESR1 Gene Mutation
EARLY/Phase 1
Interventional 12 participants sought
University of Wisconsin Carbone Cancer Center — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
Chronic Lymphocytic Leukemia
N/A
Observational 16 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Persistent Corneal Epithelial Defect
Phase 2
Interventional 84 participants sought
Glaukos Investigative Site — Madison, Wisconsin (0.8 mi)
· Sponsor: Glaukos Corporation
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
SSM Health Dean Medical Group ( Site 0106) — Madison, Wisconsin (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
University of Wisconsin - Carbone Cancer Center — Madison, Wisconsin (0.8 mi)
· Sponsor: C4 Therapeutics, Inc.
Validation of Presence-IP1.0 for Detection of Consciousness Using Reduced-Montage TMS-EEG
Sleep
N/A
Interventional 30 participants sought
UW School of Medicine and Public Health — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework
Congenital Heart Disease
N/A
Interventional 450 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
University of Wisconsin - UnityPoint Meriter — Madison, Wisconsin (0.8 mi)
· Sponsor: Children's Hospital of Philadelphia
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases
Liver Metastases, Stereotactic Body Radiation Therapy
N/A
Interventional 32 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2
Interventional 90 participants sought
University of Wisconsin-American Family Children's Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: Carl Allen
Resistant Potato Starch to Alleviate GWI
Gulf War Illness
Phase 2
Interventional 52 participants sought
William S. Middleton Memorial Veterans Hospital, Madison, WI — Madison, Wisconsin (0.8 mi)
· Sponsor: VA Office of Research and Development
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Madison, Wisconsin (0.8 mi)
· Sponsor: Sameek Roychowdhury
Well-being Skills for Reentry
Formerly Incarcerated Adults
N/A
Interventional 60 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: Pfizer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Madison, Wisconsin (0.8 mi)
· Sponsor: Daiichi Sankyo
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
NSCLC, Stage I
Phase 2
Interventional 244 participants sought
Univeristy of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Greg Durm, MD
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: NRG Oncology
A Trial to Improve Family Clinical Note Access and Outcomes for Hospitalized Children
Hospitalized Child, Pediatric Patient Safety
N/A
Interventional 630 participants sought
American Family Children's Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Kura Oncology, Inc.